Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Medicine Partners is a specialized strategy and implementation firm focused on the global scale-up of precision medicine and advanced therapies. The company works with governments, health systems, and life sciences organizations to integrate genomic medicine and data-driven healthcare into clinical practice. Their services include health system design, market access strategy, and the development of regulatory frameworks for innovative medical technologies. By bridging the gap between scientific innovation and health system delivery, they aim to accelerate the adoption of personalized healthcare solutions. The firm is led by experts with deep ties to academic institutions like Harvard University and the London School of Economics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Medicine Partners.